Bevacizumab-Induced Cutaneous Lupus Erythematosus in a Patient With Metastatic Colon Carcinoma: A Case Report

被引：0
|
作者：
Ashish, Sethi [1 ]
Raj, Moses [2 ]
Zhuang, Eric [3 ]
机构：
[1] Univ Missouri Kansas City, Infect Dis, Sch Med, Kansas City, MO 64108 USA
[2] Allegheny Hlth Network, Hematol & Oncol, Pittsburgh, PA USA
[3] Allegheny Hlth Network, Hematol & Med Oncol, Pittsburgh, PA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2024年 / 16卷 / 03期
关键词：
drug-induced lupus; cetuximab; cutaneous lupus erythematosus; metastatic colon cancer; bevacizumab; COLORECTAL-CANCER;
D O I：
10.7759/cureus.56559
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Bevacizumab, an anti -vascular epidermal growth factor inhibitor, is approved for the treatment of various cancers. Hypertension, gastrointestinal perforation, bleeding manifestations, impaired wound healing, and cerebrovascular accidents are common side effects associated with the monoclonal antibody. Uncommon cutaneous reactions like exfoliative dermatitis associated with bevacizumab have been documented in the medical literature. We present an unusual case of bevacizumab-induced cutaneous lupus in a patient with metastatic colon cancer that started resolving after discontinuing chemotherapy. Timely intervention was key in preventing the progression of this chemotherapy -induced cutaneous lupus.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Bevacizumab-Induced Pneumonitis in a Patient With Metastatic Colon Cancer: A Case Report
    Pervaiz, Sami
    Homsy, Sylvester
    Narula, Naureen
    Ngu, Sam
    Elsayegh, Dany
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
  • [2] Bevacizumab-induced Hypovascular Hepatocellular Carcinoma Treated by Transarterial Chemoembolization in a Patient with Metastatic Colon Cancer
    Iwazawa, Jin
    Ohue, Shoichi
    Hashimoto, Naoko
    Yasumasa, Keigo
    Abe, Hisashi
    Mitani, Takashi
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 21 (03) : 412 - 414
  • [3] Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report
    Abdallah, Al-Ola
    Vallurupalli, Srikanth
    Kunthur, Anuradha
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (03) : 561 - 565
  • [4] Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: A case report
    Vihinen P.
    Paija O.
    Kivisaari A.
    Koulu L.
    Aho H.
    Journal of Medical Case Reports, 5 (1)
  • [5] Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report
    Li, Jing
    Zhang, Furong
    Lu, Yuanyuan
    MEDICINE, 2023, 102 (35) : E34799
  • [6] Cutaneous Lupus Erythematosus in a Patient Undergoing Intravitreal Bevacizumab Injections: Case Report and Review of the Literature
    Cleaver, Nathan
    Ramirez, James
    Gildenberg, Stuart
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (09) : 1052 - 1055
  • [7] Bevacizumab/paclitaxelCutaneous lupus erythematosus (first report with bevacizumab) in an elderly patient: case report
    Reactions Weekly, 2011, 1368 (1) : 10 - 10
  • [8] Cutaneous lupus erythematosus induced by adalimumab: A case report
    Gonzalez-Cuevas, Ruben
    Peruilh-Bagolini, Leonardo
    Valenzuela, Fernando
    Vargas-Mora, Pablo
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [9] Bevacizumab/capecitabineDrug-induced lupus erythematosus: case report
    Reactions Weekly, 2016, 1584 (1) : 43 - 43
  • [10] Bevacizumab-Induced Esophageal Perforation: A Case Report
    Abidian, Mohamed Modar
    Nath, Anand
    Shafa, Shervin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S982 - S983
12345